{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:15:51Z","timestamp":1793211351900,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 31800737"],"award-info":[{"award-number":["Grant No. 31800737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 31800737"],"award-info":[{"award-number":["Grant No. 31800737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 31800737"],"award-info":[{"award-number":["Grant No. 31800737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 31800737"],"award-info":[{"award-number":["Grant No. 31800737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 31800737"],"award-info":[{"award-number":["Grant No. 31800737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 31800737"],"award-info":[{"award-number":["Grant No. 31800737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04059-3","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:17:14Z","timestamp":1747307834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients"],"prefix":"10.1007","volume":"74","author":[{"given":"Cairui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangli","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Along","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"3","key":"4059_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4059_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2023) Colorectal cancer statistics, 2023. CA Cancer J Clin 73(3):233\u2013254. https:\/\/doi.org\/10.3322\/caac.21772","journal-title":"CA Cancer J Clin"},{"issue":"10207","key":"4059_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394(10207):1467\u20131480. https:\/\/doi.org\/10.1016\/s0140-6736(19)32319-0","journal-title":"Lancet"},{"issue":"6","key":"4059_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH et al (2019) Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 16(6):361\u2013375. https:\/\/doi.org\/10.1038\/s41575-019-0126-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"4059_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00262-019-02343-7","volume":"68","author":"D Krijgsman","year":"2019","unstructured":"Krijgsman D, de Vries NL, Skovbo A, Andersen MN, Swets M, Bastiaannet E et al (2019) Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Cancer Immunol Immunother 68(6):1011\u20131024. https:\/\/doi.org\/10.1007\/s00262-019-02343-7","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"4059_CR6","doi-asserted-by":"publisher","first-page":"e23525","DOI":"10.1096\/fj.202301743R","volume":"38","author":"K Cao","year":"2024","unstructured":"Cao K, Wang X, Wang H, Xu C, Ma A, Zhang Y et al (2024) Phenotypic and functional exhaustion of circulating CD3(+) CD56(+) NKT-like cells in colorectal cancer patients. Faseb j 38(5):e23525. https:\/\/doi.org\/10.1096\/fj.202301743R","journal-title":"Faseb j"},{"issue":"2","key":"4059_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf NK, Kissiov DU, Raulet DH (2023) Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol 23(2):90\u2013105. https:\/\/doi.org\/10.1038\/s41577-022-00732-1","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"4059_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nri1863","volume":"6","author":"DH Raulet","year":"2006","unstructured":"Raulet DH, Vance RE (2006) Self-tolerance of natural killer cells. Nat Rev Immunol 6(7):520\u2013531. https:\/\/doi.org\/10.1038\/nri1863","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"4059_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","volume":"16","author":"S Sivori","year":"2019","unstructured":"Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC, Moretta L (2019) Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol 16(5):430\u2013441. https:\/\/doi.org\/10.1038\/s41423-019-0206-4","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"4059_CR10","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00262-021-03127-8","volume":"71","author":"J Waidhauser","year":"2022","unstructured":"Waidhauser J, Nerlinger P, Arndt TT, Schiele S, Sommer F, Wolf S et al (2022) Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma. Cancer Immunol Immunother 71(8):1937\u20131947. https:\/\/doi.org\/10.1007\/s00262-021-03127-8","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4059_CR11","doi-asserted-by":"publisher","first-page":"12188","DOI":"10.1038\/s41598-024-63103-x","volume":"14","author":"S Zu","year":"2024","unstructured":"Zu S, Lu Y, Xing R, Chen X, Zhang L (2024) Changes in subset distribution and impaired function of circulating natural killer cells in patients with colorectal cancer. Sci Rep 14(1):12188. https:\/\/doi.org\/10.1038\/s41598-024-63103-x","journal-title":"Sci Rep"},{"issue":"4","key":"4059_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/intimm\/dxm004","volume":"19","author":"MS Tessmer","year":"2007","unstructured":"Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G et al (2007) KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol 19(4):391\u2013400. https:\/\/doi.org\/10.1093\/intimm\/dxm004","journal-title":"Int Immunol"},{"issue":"11","key":"4059_CR13","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3755::AID-IMMU3755>3.0.CO;2-3","volume":"28","author":"S Butcher","year":"1998","unstructured":"Butcher S, Arney KL, Cook GP (1998) MAFA-L, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells. Eur J Immunol 28(11):3755\u20133762","journal-title":"Eur J Immunol"},{"issue":"10","key":"4059_CR14","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1182\/blood-2002-02-0657","volume":"100","author":"D Voehringer","year":"2002","unstructured":"Voehringer D, Koschella M, Pircher H (2002) Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 100(10):3698\u20133702. https:\/\/doi.org\/10.1182\/blood-2002-02-0657","journal-title":"Blood"},{"issue":"3","key":"4059_CR15","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.4049\/jimmunol.176.3.1311","volume":"176","author":"C Gr\u00fcndemann","year":"2006","unstructured":"Gr\u00fcndemann C, Bauer M, Schweier O, von Oppen N, L\u00e4ssing U, Saudan P et al (2006) Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol 176(3):1311\u20131315. https:\/\/doi.org\/10.4049\/jimmunol.176.3.1311","journal-title":"J Immunol"},{"issue":"2","key":"4059_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1084\/jem.20051986","volume":"203","author":"M Ito","year":"2006","unstructured":"Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N (2006) Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med 203(2):289\u2013295. https:\/\/doi.org\/10.1084\/jem.20051986","journal-title":"J Exp Med"},{"issue":"9","key":"4059_CR17","doi-asserted-by":"publisher","first-page":"e005061","DOI":"10.1136\/jitc-2022-005061","volume":"10","author":"C Lou","year":"2022","unstructured":"Lou C, Wu K, Shi J, Dai Z, Xu Q (2022) N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor. J Immunother Cancer 10(9):e005061. https:\/\/doi.org\/10.1136\/jitc-2022-005061","journal-title":"J Immunother Cancer"},{"issue":"4","key":"4059_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/ajco.13723","volume":"18","author":"X Zeng","year":"2022","unstructured":"Zeng X, Yao D, Liu L, Zhang Y, Lai J, Zhong J et al (2022) Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT(+) NK cells may be related to poor outcome in acute myeloid leukemia. Asia Pac J Clin Oncol 18(4):456\u2013464. https:\/\/doi.org\/10.1111\/ajco.13723","journal-title":"Asia Pac J Clin Oncol"},{"issue":"9","key":"4059_CR19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/s1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA et al (2017) Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 18(9):1182\u20131191. https:\/\/doi.org\/10.1016\/s1470-2045(17)30422-9","journal-title":"Lancet Oncol"},{"issue":"8","key":"4059_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/jco.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M et al (2018) Durable clinical benefit with Nivolumab plus Ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 36(8):773\u2013779. https:\/\/doi.org\/10.1200\/jco.2017.76.9901","journal-title":"J Clin Oncol"},{"issue":"23","key":"4059_CR21","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C et al (2020) Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med 383(23):2207\u20132218. https:\/\/doi.org\/10.1056\/NEJMoa2017699","journal-title":"N Engl J Med"},{"issue":"17","key":"4059_CR22","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2174\/0929867324666170804143706","volume":"26","author":"B Li","year":"2019","unstructured":"Li B, Chan HL, Chen P (2019) Immune checkpoint inhibitors: basics and challenges. Curr Med Chem 26(17):3009\u20133025. https:\/\/doi.org\/10.2174\/0929867324666170804143706","journal-title":"Curr Med Chem"},{"issue":"1","key":"4059_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","volume":"19","author":"S-Y Wu","year":"2020","unstructured":"Wu S-Y, Fu T, Jiang Y-Z, Shao Z-M (2020) Natural killer cells in cancer biology and therapy. Mol Cancer 19(1):120. https:\/\/doi.org\/10.1186\/s12943-020-01238-x","journal-title":"Mol Cancer"},{"issue":"4","key":"4059_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/1078-0432.Ccr-10-2173","volume":"17","author":"N Halama","year":"2011","unstructured":"Halama N, Braun M, Kahlert C, Spille A, Quack C, Rahbari N et al (2011) Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res 17(4):678\u2013689. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-2173","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4059_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1753425912453187","volume":"19","author":"YS Rocca","year":"2012","unstructured":"Rocca YS, Roberti MP, Arriaga JM, Amat M, Bruno L, Pampena MB et al (2012) Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients. Innate Immun 19(1):76\u201385. https:\/\/doi.org\/10.1177\/1753425912453187","journal-title":"Innate Immun"},{"issue":"1","key":"4059_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12876-020-1177-8","volume":"20","author":"Y-p Tang","year":"2020","unstructured":"Tang Y-p, Xie M-z, Li K-z, Li J-l, Cai Z-m, Hu B-l (2020) Prognostic value of peripheral blood natural killer cells in colorectal cancer. BMC Gastroenterol 20(1):31. https:\/\/doi.org\/10.1186\/s12876-020-1177-8","journal-title":"BMC Gastroenterol"},{"key":"4059_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fimmu.2016.00413","volume":"7","author":"YS Rocca","year":"2016","unstructured":"Rocca YS, Roberti MP, Juli\u00e1 EP, Pampena MB, Bruno L, Rivero S et al (2016) Phenotypic and functional dysregulated blood NK cells in colorectal cancer patients can be activated by Cetuximab plus IL-2 or IL-15. Front Immunol 7:413. https:\/\/doi.org\/10.3389\/fimmu.2016.00413","journal-title":"Front Immunol"},{"issue":"5","key":"4059_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9(5):503\u2013510. https:\/\/doi.org\/10.1038\/ni1582","journal-title":"Nat Immunol"},{"key":"4059_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","volume":"31","author":"EO Long","year":"2013","unstructured":"Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 31:227\u2013258. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075005","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"4059_CR30","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","volume":"121","author":"E Mamessier","year":"2011","unstructured":"Mamessier E, Sylvain A, Thibult M-L, Houvenaeghel G, Jacquemier J, Castellano R et al (2011) Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Investig 121(9):3609\u20133622. https:\/\/doi.org\/10.1172\/JCI45816","journal-title":"J Clin Investig"},{"issue":"1","key":"4059_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1479-5876-11-262","volume":"11","author":"Y-P Peng","year":"2013","unstructured":"Peng Y-P, Zhu Y, Zhang J-J, Xu Z-K, Qian Z-Y, Dai C-C et al (2013) Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J Transl Med 11(1):262. https:\/\/doi.org\/10.1186\/1479-5876-11-262","journal-title":"J Transl Med"},{"issue":"6","key":"4059_CR32","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4049\/jimmunol.168.6.2585","volume":"168","author":"SH Robbins","year":"2002","unstructured":"Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, Brossay L (2002) Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J Immunol 168(6):2585\u20132589. https:\/\/doi.org\/10.4049\/jimmunol.168.6.2585","journal-title":"J Immunol"},{"issue":"11","key":"4059_CR33","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.4049\/jimmunol.167.11.6394","volume":"167","author":"R Xu","year":"2001","unstructured":"Xu R, Abramson J, Fridkin M, Pecht I (2001) SH2 domain-containing inositol polyphosphate 5\u2032-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen. J Immunol 167(11):6394\u20136402. https:\/\/doi.org\/10.4049\/jimmunol.167.11.6394","journal-title":"J Immunol"},{"issue":"26","key":"4059_CR34","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1182\/blood-2009-06-228353","volume":"114","author":"C Banh","year":"2009","unstructured":"Banh C, Fug\u00e8re C, Brossay L (2009) Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling. Blood 114(26):5299\u20135306. https:\/\/doi.org\/10.1182\/blood-2009-06-228353","journal-title":"Blood"},{"issue":"4","key":"4059_CR35","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.3892\/ol.2016.4309","volume":"11","author":"J Daragmeh","year":"2016","unstructured":"Daragmeh J, Barriah W, Saad B, Zaid H (2016) Analysis of PI3K pathway components in human cancers. Oncol Lett 11(4):2913\u20132918. https:\/\/doi.org\/10.3892\/ol.2016.4309","journal-title":"Oncol Lett"},{"issue":"1","key":"4059_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12964-024-01714-7","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen S, Tang X, Peng Y, Jiang T, Zhang X et al (2024) The role of KLRG1: a novel biomarker and new therapeutic target. Cell Commun Signal 22(1):337. https:\/\/doi.org\/10.1186\/s12964-024-01714-7","journal-title":"Cell Commun Signal"},{"issue":"26","key":"4059_CR37","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1182\/blood-2009-01-199588","volume":"113","author":"SM Henson","year":"2009","unstructured":"Henson SM, Franzese O, Macaulay R, Libri V, Azevedo RI, Kiani-Alikhan S et al (2009) KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 113(26):6619\u20136628. https:\/\/doi.org\/10.1182\/blood-2009-01-199588","journal-title":"Blood"},{"issue":"22","key":"4059_CR38","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1182\/blood.V114.22.3690.3690","volume":"114","author":"M Krusch","year":"2009","unstructured":"Krusch M, Salih J, Kumbier I, Fenner C, Kanz L, Salih HR (2009) The role of the PI3K-AKT-mTOR pathway in NK cell anti-tumor reactivity. Blood 114(22):3690. https:\/\/doi.org\/10.1182\/blood.V114.22.3690.3690","journal-title":"Blood"},{"issue":"21","key":"4059_CR39","doi-asserted-by":"publisher","first-page":"11626","DOI":"10.1128\/jvi.01515-13","volume":"87","author":"JM Wang","year":"2013","unstructured":"Wang JM, Cheng YQ, Shi L, Ying RS, Wu XY, Li GY et al (2013) KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection. J Virol 87(21):11626\u201311636. https:\/\/doi.org\/10.1128\/jvi.01515-13","journal-title":"J Virol"},{"issue":"7","key":"4059_CR40","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.4049\/jimmunol.1600590","volume":"197","author":"B M\u00fcller-Durovic","year":"2016","unstructured":"M\u00fcller-Durovic B, Lanna A, Covre LP, Mills RS, Henson SM, Akbar AN (2016) Killer cell lectin-like receptor G1 inhibits NK cell function through activation of adenosine 5\u2032-monophosphate-activated protein kinase. J Immunol 197(7):2891\u20132899. https:\/\/doi.org\/10.4049\/jimmunol.1600590","journal-title":"J Immunol"},{"key":"4059_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.arr.2016.04.003","volume":"28","author":"A Salminen","year":"2016","unstructured":"Salminen A, Kaarniranta K, Kauppinen A (2016) Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Res Rev 28:15\u201326. https:\/\/doi.org\/10.1016\/j.arr.2016.04.003","journal-title":"Ageing Res Rev"},{"issue":"4","key":"4059_CR42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/cncr.21260","volume":"104","author":"AO Chan","year":"2005","unstructured":"Chan AO, Chu KM, Lam SK, Cheung KL, Law S, Kwok KF et al (2005) Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer 104(4):740\u2013746. https:\/\/doi.org\/10.1002\/cncr.21260","journal-title":"Cancer"},{"issue":"12","key":"4059_CR43","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/ijc.29982","volume":"138","author":"QP Hu","year":"2016","unstructured":"Hu QP, Kuang JY, Yang QK, Bian XW, Yu SC (2016) Beyond a tumor suppressor: soluble E-cadherin promotes the progression of cancer. Int J Cancer 138(12):2804\u20132812. https:\/\/doi.org\/10.1002\/ijc.29982","journal-title":"Int J Cancer"},{"issue":"2","key":"4059_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe 14(2):195\u2013206. https:\/\/doi.org\/10.1016\/j.chom.2013.07.012","journal-title":"Cell Host Microbe"},{"issue":"18","key":"4059_CR45","doi-asserted-by":"publisher","first-page":"12112","DOI":"10.1128\/jvi.79.18.12112-12116.2005","volume":"79","author":"R Thimme","year":"2005","unstructured":"Thimme R, Appay V, Koschella M, Panther E, Roth E, Hislop AD et al (2005) Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J Virol 79(18):12112\u201312116. https:\/\/doi.org\/10.1128\/jvi.79.18.12112-12116.2005","journal-title":"J Virol"},{"issue":"10","key":"4059_CR46","doi-asserted-by":"publisher","first-page":"101202","DOI":"10.1016\/j.xcrm.2023.101202","volume":"4","author":"A Astorga-Gamaza","year":"2023","unstructured":"Astorga-Gamaza A, Perea D, Sanchez-Gaona N, Calvet-Mirabent M, Gallego-Cort\u00e9s A, Grau-Exp\u00f3sito J et al (2023) KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir. Cell Rep Med 4(10):101202. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101202","journal-title":"Cell Rep Med"},{"issue":"1","key":"4059_CR47","doi-asserted-by":"publisher","first-page":"1933808","DOI":"10.1080\/2162402x.2021.1933808","volume":"10","author":"A Tata","year":"2021","unstructured":"Tata A, Dodard G, Fug\u00e8re C, Leget C, Ors M, Rossi B et al (2021) Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers. Oncoimmunology 10(1):1933808. https:\/\/doi.org\/10.1080\/2162402x.2021.1933808","journal-title":"Oncoimmunology"},{"issue":"9","key":"4059_CR48","doi-asserted-by":"publisher","first-page":"e202001134","DOI":"10.1083\/jcb.202001134","volume":"219","author":"IS Chan","year":"2020","unstructured":"Chan IS, Kn\u00fatsd\u00f3ttir H, Ramakrishnan G, Padmanaban V, Warrier M, Ramirez JC et al (2020) Cancer cells educate natural killer cells to a metastasis-promoting cell state. J Cell Biol. 219(9):e202001134. https:\/\/doi.org\/10.1083\/jcb.202001134","journal-title":"J Cell Biol."},{"issue":"6_Supplement","key":"4059_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/1538-7445.Am2024-177","volume":"84","author":"TA Jones","year":"2024","unstructured":"Jones TA, Sinicrope S, Yasuda K, Pinkas J, Gajewski TF (2024) Abstract 177: Targeting murine or human KLRG1 exerts potent anti-tumor efficacy involving both CD8T cells and NK cells. Cancer Res 84(6_Supplement):177. https:\/\/doi.org\/10.1158\/1538-7445.Am2024-177","journal-title":"Cancer Res"},{"issue":"14","key":"4059_CR50","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.18632\/oncotarget.26659","volume":"10","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA, Kong SW, Thompson E, Gulla SV (2019) Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models. Oncotarget 10(14):1399\u20131406. https:\/\/doi.org\/10.18632\/oncotarget.26659","journal-title":"Oncotarget"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04059-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:16:03Z","timestamp":1749896163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04059-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4059"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04059-3","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of the First Affiliated Hospital of Anhui Medical University (PJ 2024-12-16).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"203"}}